Villin expression in human tumors: a tissue microarray study on 14,398 tumors

References

• Nakamura E, Iwakawa M, Furuta R, et al. Villin1, a novel diagnostic marker for cervical adenocarcinoma. Cancer Biol Ther. 2009;8(12):1146–1153.
   PubMed Web of Science ®Google Scholar
• George SP, Wang Y, Mathew S, et al. Dimerization and actin-bundling properties of villin and its role in the assembly of epithelial cell brush borders. J Biol Chem. 2007;282(36):26528–26541.
   PubMed Web of Science ®Google Scholar
• Bretscher A, Weber K. Villin is a major protein of the microvillus cytoskeleton which binds both G and F actin in a calcium-dependent manner. Cell. 1980;20(3):839–847.
   PubMed Web of Science ®Google Scholar
• Delacour D, Salomon J, Robine S, et al. Plasticity of the brush border - the yin and yang of intestinal homeostasis. Nat Rev Gastroenterol Hepatol. 2016;13(3):161–174.
   PubMed Web of Science ®Google Scholar
• Grone HJ, Weber K, Helmchen U, et al. Villin–a marker of brush border differentiation and cellular origin in human renal cell carcinoma. Am J Pathol. 1986;124(2):294–302.
   PubMed Web of Science ®Google Scholar
• Wang Y, George SP, Roy S, et al. Both the anti- and pro-apoptotic functions of villin regulate cell turnover and intestinal homeostasis. Sci Rep. 2016;6:35491.
   PubMed Web of Science ®Google Scholar
• Robine S, Huet C, Moll R, et al. Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc Natl Acad Sci U S A. 1985;82(24):8488–8492.
   PubMed Web of Science ®Google Scholar
• Merchant SH, Amin MB, Tamboli P, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001;25(12):1515–1519.
   PubMed Web of Science ®Google Scholar
• Moll R, Robine S, Dudouet B, et al. Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;54(3):155–169.
   PubMedGoogle Scholar
• Droz D, Zachar D, Charbit L, et al. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol. 1990;137(4):895–905.
   PubMed Web of Science ®Google Scholar
• Lin F, Shi J, Zhu S, et al. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138(8):1015–1026.
   PubMed Web of Science ®Google Scholar
• Al-Maghrabi J, Gomaa W, Buhmeida A, et al. Loss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survival. ISRN Gastroenterol. 2013;2013:679724.
   PubMedGoogle Scholar
• Zhang MQ, Lin F, Hui P, et al. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. Am J Clin Pathol. 2007;128(5):808–816.
   PubMed Web of Science ®Google Scholar
• Mizoshita T, Tsukamoto T, Inada KI, et al. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol. 2007;22(3):251–260.
   PubMed Web of Science ®Google Scholar
• Suh N, Yang XJ, Tretiakova MS, et al. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18(9):1217–1222.
   PubMed Web of Science ®Google Scholar
• Nishizuka S, Chen S-T, Gwadry FG, et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 2003;63(17):5243–5250.
   PubMed Web of Science ®Google Scholar
• Cao HH, Zhang S-Y, Shen J-H, et al. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 2015;6(7):5435–5448.
   PubMedGoogle Scholar
• Peng ZM, Yu W, Xie Y, et al. A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2014;7(9):5950–5959.
   PubMed Web of Science ®Google Scholar
• Weimann A, Rieger A, Zimmermann M, et al. Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett’s esophagus. Virchows Arch. 2010;457(5):537–545.
   PubMed Web of Science ®Google Scholar
• Pereira TC, Share SM, and Magalhães AV, et al. Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases. Appl Immunohistochem Mol Morphol. 2011;19(1):10–14.
   PubMedGoogle Scholar
• Anders M, Sarbia M, Grotzinger C, et al. Expression of EpCam and villin in Barrett’s esophagus and in gastric cardia. Dis Markers. 2008;24(6):287–292.
   PubMed Web of Science ®Google Scholar
• Regalado SP, Nambu Y, and Iannettoni MD, et al. Abundant expression of the intestinal protein villin in Barrett’s metaplasia and esophageal adenocarcinomas. Mol Carcinog. 1998;22(3):182–189.
   PubMed Web of Science ®Google Scholar
• Seipel AH, Samaratunga H, Delahunt B, et al. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study. APMIS. 2016;124(4):263–270.
   PubMed Web of Science ®Google Scholar
• Gushima R, Yao T, Kurisaki-Arakawa A, et al. Expression of adipophilin in gastric epithelial neoplasia is associated with intestinal differentiation and discriminates between adenoma and adenocarcinoma. Virchows Arch. 2016;468(2):169–177.
   PubMed Web of Science ®Google Scholar
• Ran X, Xu X, and Yang Y, et al. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer. Int J Oncol. 2015;47(5):1932–1944.
   PubMed Web of Science ®Google Scholar
• Tian MM, Zhao AL, and Li ZW, et al. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis. World J Gastroenterol. 2007;13(23):3189–3198.
   PubMed Web of Science ®Google Scholar
• Yang Z. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer. Appl Immunohistochem Mol Morphol. 2015;23(1):19–25.
   PubMedGoogle Scholar
• Al-Muhannadi N, Ansari N, Brahmi U, et al. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material. Ann Hepatol. 2011;10(4):508–515.
   PubMed Web of Science ®Google Scholar
• Lau SK, Prakash S, and Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33(12):1175–1181.
   PubMed Web of Science ®Google Scholar
• Nogales FF, Prat J, Schuldt M, et al. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells. Histopathol. 2018;72(4):634–647.
   PubMed Web of Science ®Google Scholar
• Roy S, Smith MA, Cieply KM, et al. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol. 2012;7:151.
   PubMed Web of Science ®Google Scholar
• Bian T, Zhao J, Feng J, et al. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma. Oncotarget. 2017;8(38):63442–63452.
   PubMedGoogle Scholar
• Calio A, Lever V, Rossi A, et al. Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis. Histopathol. 2017;71(5):725–735.
   PubMed Web of Science ®Google Scholar
• Wang CX, Liu B, Wang Y-F, et al. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. Int J Clin Exp Pathol. 2014;7(3):1266–1274.
   PubMed Web of Science ®Google Scholar
• Goldstein NS, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am J Clin Pathol. 2001;116(3):319–325.
   PubMed Web of Science ®Google Scholar
• Nambu Y, Iannettoni MD, Orringer MB, et al. Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas. Mol Carcinog. 1998;23(4):234–242.
   PubMed Web of Science ®Google Scholar
• Tan J, Sidhu G, Greco MA, et al. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Hum Pathol. 1998;29(4):390–396.
   PubMed Web of Science ®Google Scholar
• Nakamura E, Satoh T, Iwakawa M, et al. Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia. Cancer Biol Ther. 2011;12(3):181–190.
   PubMed Web of Science ®Google Scholar
• Dancau AM, Simon R, and Mirlacher M, et al. Tissue microarrays. Methods Mol Biol. 2016;1381:53–65.
   PubMedGoogle Scholar
• Mirlacher M, Simon R. Recipient block TMA technique. Methods Mol Biol. 2010;664:37–44.
   PubMedGoogle Scholar
• Kononen J, Bubendorf L, and Kallioniemie A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844–847.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Bandrowski A, Carr S, et al. A proposal for validation of antibodies. Nat Methods. 2016;13(10):823–827.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerbeg L, and Hallström BM , et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. DOI:10.1126/science.1260419.
   PubMed Web of Science ®Google Scholar
• Lizio M, Abugessaisa I, and Noguchi S , et al. Update of the FANTOM web resource: expansion to provide additional transcriptome atlases. Nucleic Acids Res. 2019;47(D1):D752–D758.
   PubMed Web of Science ®Google Scholar
• Lizio M, Harshbarger J, Shimoji H, et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 2015;16:22.
   PubMed Web of Science ®Google Scholar
• Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580–585.
   PubMed Web of Science ®Google Scholar
• Maunoury R, Robine S, Pringault E, et al. Villin expression in the visceral endoderm and in the gut anlage during early mouse embryogenesis. EMBO J. 1988;7(11):3321–3329.
   PubMed Web of Science ®Google Scholar
• Nogales FF, Quiñonez E, López-Marín L, et al. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac. Histopathol. 2014;65(1):51–59.
   PubMed Web of Science ®Google Scholar
• Nogales FF, Dulcey I. The secondary human yolk sac has an immunophenotype indicative of both hepatic and intestinal differentiation. Int J Dev Biol. 2012;56(9):755–760.
   PubMed Web of Science ®Google Scholar
• Sun L, Sakurai S, Sano T, et al. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Pathol Int. 2009;59(8):522–529.
   PubMed Web of Science ®Google Scholar
• Zhang PJ, Harris KR, and Alobeid B, et al. Immunoexpression of villin in neuroendocrine tumors and its diagnostic implications. Arch Pathol Lab Med. 1999;123(9):812–816.
   PubMed Web of Science ®Google Scholar
• Seidman JD, Yemelyanova A, and Zaino RJ, et al. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol. 2011;30(1):4–11.
   PubMed Web of Science ®Google Scholar
• Arango D, Al-Obaidi S, and Williams DS, et al. Villin expression is frequently lost in poorly differentiated colon cancer. Am J Pathol. 2012;180(4):1509–1521.
   PubMed Web of Science ®Google Scholar